Related Experiment Video
Updated: Jun 12, 2026

Evaluation of Substrate Ubiquitylation by E3 Ubiquitin-ligase in Mammalian Cell Lysates
Published on: May 10, 2022
Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells
Seung H Choi1, Jason B Wright, Scott A Gerber
1Department of Genetics, Dartmouth Medical School, Norris Cotton Cancer Center, Lebanon, New Hampshire 03756, USA.
Abstract:
Rapid Myc protein turnover is critical for maintaining basal levels of Myc activity in normal cells and a prompt response to changing growth signals. We characterize a new Myc-interacting factor, TRPC4AP (transient receptor potential cation channel, subfamily C, member 4-associated protein)/TRUSS (tumor necrosis factor receptor-associated ubiquitous scaffolding and signaling protein), which is the receptor for a DDB1 (damage-specific DNA-binding protein 1)-CUL4 (Cullin 4) E3 ligase complex for selective Myc degradation through the proteasome. TRPC4AP/TRUSS binds specifically to the Myc C terminus and promotes its ubiquitination and destruction through the recognition of evolutionarily conserved domains in the Myc N terminus. TRPC4AP/TRUSS suppresses Myc-mediated transactivation and transformation in a dose-dependent manner. Finally, we found that TRPC4AP/TRUSS expression is strongly down-regulated in most cancer cell lines, leading to Myc protein stabilization. These studies identify a novel pathway targeting Myc degradation that is suppressed in cancer cells.
Insights
A newly discovered protein, TRPC4AP/TRUSS, targets Myc for degradation, crucial for cell growth. Its reduced expression in cancer stabilizes Myc, promoting tumor growth.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- Myc protein turnover is essential for normal cell growth and response to signals.
- Dysregulation of Myc contributes to cancer development.
Purpose of the Study:
- To identify and characterize novel regulators of Myc protein degradation.
- To investigate the role of TRPC4AP/TRUSS in Myc regulation and cancer.
Main Methods:
- Protein-protein interaction studies to identify Myc-binding partners.
- Ubiquitination assays to assess Myc modification.
- Cell-based assays to evaluate Myc transactivation and transformation.
- Analysis of TRPC4AP/TRUSS expression in cancer cell lines.
Main Results:
- TRPC4AP/TRUSS, a receptor for a DDB1-CUL4 E3 ligase complex, selectively degrades Myc via the proteasome.
- TRPC4AP/TRUSS binds Myc and promotes its ubiquitination and destruction.
- TRPC4AP/TRUSS suppresses Myc-driven transactivation and transformation.
- TRPC4AP/TRUSS expression is significantly downregulated in most cancer cell lines, leading to Myc stabilization.
Conclusions:
- TRPC4AP/TRUSS represents a novel pathway for Myc degradation.
- The suppression of this pathway in cancer contributes to Myc protein stabilization and oncogenesis.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...

